Healthcare ❯ Oncology

Cancer Treatments

Combination Therapies Bladder Cancer

Pfizer Lifts 2025 EPS Outlook, Targets $7.7 Billion in Savings as Dividend Draws Interest

Recent coverage spotlights dividend strength plus late-stage oncology momentum following a steep three-year stock slide.

Pfizer’s Updated COVID-19 Vaccine Shows Strong Phase 3 Immune Response for 2025–2026 Formula